Vitality Watch

Dossier clinicaltrials trial early 13-jul-2026
Small or early-phase human trial or pilot study

The Effects of an AIoT-Based Exercise System on Frail Older Adults

Key claim: An AIoT-based feedback assistive strengthening ergometer (AIFASE) is being tested in a clinical trial for effects on muscle strength, physical fitness, functional performance, and frailty severity in frail older adults in geriatric wards.

Abstract

This clinical trial aims to evaluate the effectiveness of an Artificial Intelligence of Things (AIoT)-based feedback assistive strengthening ergometer (AIFASE) exercise system on frail older adults in geriatric wards. Baseline assessments will include physical fitness, functional performance, and frailty severity. Muscle strength of the major muscle groups in the upper and lower extremities will be evaluated at both baseline and post-intervention. Throughout the intervention, exercise-related data, including exercise duration, workload, heart rate, rate of perceived exertion (RPE), and blood oxygen saturation (SpO2) will be continuously and simultaneously collected for analysis.

Why this matters

An AIoT-based feedback assistive strengthening ergometer (AIFASE) is being tested in a clinical trial for effects on muscle strength, physical fitness, functional performance, and frailty severity in frail older adults in geriatric wards.

Source

Link

Briefing card

The Effects of an AIoT-Based Exercise System on Frail Older Adults
Stage: trial early · clinicaltrials · 13-jul-2026

An AIoT-based feedback assistive strengthening ergometer (AIFASE) is being tested in a clinical trial for effects on muscle strength, physical fitness, functional performance, and frailty severity in frail older adults in geriatric wards.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT07698912

build build 880 · 2bcef25 · 2026-11-18